These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1273213)

  • 21. Paradoxical akinetic response to apomorphine in parkinsonism.
    Jenkins JR; Pearce JM
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):414-5. PubMed ID: 1602324
    [No Abstract]   [Full Text] [Related]  

  • 22. [Apomorphine in the biochemical concept of Parkinson's tremor].
    Brinkmann R; Strian F
    Nervenarzt; 1974 Sep; 45(9):474-6. PubMed ID: 4437688
    [No Abstract]   [Full Text] [Related]  

  • 23. 10 questions about using apomorphine for Parkinson disease.
    Dewey RB
    Neurologist; 2005 May; 11(3):190-2. PubMed ID: 15860144
    [No Abstract]   [Full Text] [Related]  

  • 24. [Benefit and risk of high-dose metoclopramide in comparison to high-dose haloperidol or triflupromazine in cisplatin-induced vomiting].
    Saller R; Hellenbrecht D
    Klin Wochenschr; 1985 May; 63(9):428-32. PubMed ID: 4039775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine receptors and sleep induction in man.
    Bassi S; Albizzati MG; Frattola L; Passerini D; Trabucchi M
    J Neurol Neurosurg Psychiatry; 1979 May; 42(5):458-60. PubMed ID: 448384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metoclopramide in the reduction of nausea and vomiting associated with combined chemotherapy.
    Cox R; Newman CE; Leyland MJ
    Cancer Chemother Pharmacol; 1982; 8(1):133-5. PubMed ID: 7046974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of REM and delta sleep by apomorphine in man: a dopamine mimetic effect.
    Cianchetti C; Masala C; Mangoni A; Gessa GL
    Psychopharmacology (Berl); 1980 Jan; 67(1):61-5. PubMed ID: 6768079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of neuroleptic drugs on the inhibition of exploratory behaviour induced by a low dose of apomorphine: implications for the identity of dopamine receptors.
    Ståhle L; Ungerstedt U
    Pharmacol Biochem Behav; 1986 Aug; 25(2):473-80. PubMed ID: 2876441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of anti-emetic effects of ondansetron, metoclopromide or a combination of both in children undergoing surgery for strabismus.
    Kathirvel S; Shende D; Madan R
    Eur J Anaesthesiol; 1999 Nov; 16(11):761-5. PubMed ID: 10713869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of levosulpiride versus metoclopramide for nausea and vomiting in advanced cancer patients: a double-blind, randomized, crossover study.
    Corli O; Cozzolino A; Battaiotto L
    J Pain Symptom Manage; 1995 Oct; 10(7):521-6. PubMed ID: 8537694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment.
    Priano L; Albani G; Brioschi A; Guastamacchia G; Calderoni S; Lopiano L; Rizzone M; Cavalli R; Gasco MR; Fraschini F; Bergamasco B; Mauro A
    Neurol Sci; 2003 Oct; 24(3):207-8. PubMed ID: 14598090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease.
    Merello M; Lees AJ
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1024-6. PubMed ID: 1469397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study.
    Köseoglu V; Kürekçi AE; Sarici U; Atay AA; Ozcan O
    Eur J Pediatr; 1998 Oct; 157(10):806-10. PubMed ID: 9809818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actions of dopaminergic agonists in parkinsonism.
    McDowell FH; Sweet R
    Adv Neurol; 1975; 9():367-71. PubMed ID: 1096573
    [No Abstract]   [Full Text] [Related]  

  • 35. Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
    Malik I; Moid I; Khan Z; Hussain M
    Am J Clin Oncol; 1999 Apr; 22(2):126-30. PubMed ID: 10199444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
    Kenward H; Elliott J; Lee T; Pelligand L
    BMC Vet Res; 2017 Aug; 13(1):244. PubMed ID: 28814338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone].
    Senn HJ; Köhler M; Glaus A; Bachmann-Mettler I; Weigand W
    Dtsch Med Wochenschr; 1986 Jan; 111(4):129-35. PubMed ID: 3510848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis.
    Miner WD; Sanger GJ; Turner DH
    Br J Cancer; 1987 Aug; 56(2):159-62. PubMed ID: 3311109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apomorphine in the diagnosis and treatment of parkinsonian tremor.
    Hughes AJ; Lees AJ; Stern GM
    Clin Neuropharmacol; 1990 Aug; 13(4):312-7. PubMed ID: 2208183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
    Gebbia V; Testa A; Valenza R; Cannata G; Tirrito ML; Gebbia N
    Cancer; 1995 Nov; 76(10):1821-8. PubMed ID: 8625054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.